• Resverlogix Obtains Funding for Phase 2 Trial Testing Apabetalone in PAH
  • Opsumit Has Potential to Improve Right Ventricle Function in PAH Patients, Phase 4 Data Show
  • Cell Therapies Show Potential as Treatment for PAH, Review Finds
  • Defining Five Main Categories of Pulmonary Wellness: A Rehab Specialist’s Advice
  • Estrogen May Help Protect Against Heart Changes in PAH, Animal Study Suggests
  • PH Life Feels Like Residing in a Waiting Room
  • Liquidia’s LIQ861 Safe and Effective in PAH Patients, Phase 3 Trial Suggests
  • Brexit Could Have Real Effects for UK Rare Disease Patients, Experts Warn
  • 1st Participant Enrolled in Phase 2 Trial of Levosimendan for PH Patients with Heart Failure
  • Moral Dilemmas Complicate Treatment of Rare Diseases, Says Israeli Bioethicist
  • Study Reveals Possible Reason for Women’s Higher Risk of PAH
  • With PH, I Choose to Be Cautiously Optimistic